UK's £150M AI Accelerator: Strategic Investment Reshapes Pharma Innovation
Setting the Scene: A New Dawn for AI in the UK On a crisp morning in London, the UK Knowledge Quarter marked a pivotal moment with the launch of an AI Accelerator, led by Boehringer Ingelheim. Backed
This investment could reshape the landscape of pharmaceutical innovation and establish the UK as a key player in AI technology.
